Diamonds and Dogs


Apple (AAPL) shining brightly. Apple is jumping 4% following better than expected earnings and sales. Each geographical area grew at least 25%. Apple also raised guidance for the current quarter. The cash keeps coming in. Apple has over $260 billion in cash and will add $100 billion to their buyback plan. The company also raised their dividend 16%. Plenty of upgrades with price target of $190, $200, $208, $214, and $225.

Good news Gilead (GILD) is curing everyone. The bad news is the stock is lower. Product sales came in at $5.0 billion, down 21.6% year over year due to accelerated decline in HCV sales. Antiviral product sales, which include Gilead's HIV and liver disease portfolio, came in at $4.4 billion in the quarter, down 24.1% from the year-ago quarter. Not a lot of great news in the short term, but one analyst sees multiple catalysts this year and next, and a robust balance sheet that could allow it to do more M&A to expand its pipeline. Let's hope he's right.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.